KVISTGAARD, Denmark - March 4, 2015 - Earlier today, Bavarian Nordic announced an investor and analyst conference call on Thursday, March 5, 2015 to discuss the agreement with Bristol-Myers Squibb for PROSTVAC that the was announced this morning.
The Company will not hold this conference call, but will address questions relating to the agreement with Bristol-Myers Squibb at a conference call next week, relating to the publication of the Companys 2014 annual report on Wednesday, March 11. Further details will follow.
For questions, please contact our investor relations at investor@bavarian-nordic.com.
Contacts
U.S.: Seth Lewis, Vice President, Investor Relations. Phone: + 1 978-341-5271
Europe: Rolf Sass Sørensen, Vice President Investor Relations & Communications. Phone +45 61 77 47 43